**Study Overview**: This research aims to check if the drug LY4065967 is safe and effective for knee pain from osteoarthritis (OA). Osteoarthritis is when the protective tissue at the ends of bones wears down, causing joint pain. This study is part of a bigger plan called the Chronic Pain Master Protocol (H0P-MC-CPMP) to speed up finding new treatments for long-term pain. **Eligibility**: Participants should have had knee pain for over 12 weeks, an x-ray showing OA, and a body mass index (BMI) of 40 or less. They should also have stable blood sugar levels, shown by a glycated hemoglobin (HbA1c) of 10 or less. Pregnant or breastfeeding women, people with recent knee surgery, or those with certain medical conditions cannot join. **Key Points**: - **Study Length**: The exact duration isn't mentioned; participants should ask about this. - **Visits Required**: Check how many clinic visits are needed. - **Compensation**: Ask if there's any payment for participating. This study could help discover new ways to ease knee pain, but it's important to ensure you meet the criteria and understand the commitments before joining.